IMPROVING PATIENT SAFETY 13
References
Grissinger, M. (2017). "Wrong patient" insulin pen injections alarmingly frequent even with
barcode scanning. P & T, 42(9), 550-552.
Herdman, M. L., Larck, C., Schliesser, S. H., & Jelic, T. M. (2013). Biological contamination of
insulin pens in a hospital setting. American Journal of Health-System Pharmacy, 70(14),
1244-1248.
Institute of Safe Medication Practices. (2017). ISMP guidelines for optimizing safe subcutaneous
insulin use in adults. Retrieved 10 November 2017 from
http://www.diabetesincontrol.com/wp-content/uploads/2017/05/Insulin-Guidelines-for-
Safety.pdf.
Le Flotch J.-P., Herbreteau, C., Lange, F., & Perlemuter, L. (1998). Biologic material in needles
and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care, 21(9),
1502-1504.
Paparella, S. F. (2015). Insulin pens: Single patient use is mandatory for safety. Journal of
Emergency Nursing, 41(4), 340-342.
Sonoki, K., Yoshinari, M., Iwase, M., Tashiro, K., Iino, K., Wakisaka, M., & Fujishima, M.
(2001). Regurgitation of blood into insulin cartridges in the pen-like injectors. Diabetes
Care, 24(3), 603-604.
Truong, T. H., Nguyen, T. T., Armor, B. L., & Farley, J. R. (2017). Errors in the administration
technique of insulin pen devices: A result of insufficient education. Diabetes Therapy,
8(2), 221-226.